nodes	percent_of_prediction	percent_of_DWPC	metapath
Trihexyphenidyl—Diphenidol—Bepridil—hypertension	0.222	1	CrCrCtD
Trihexyphenidyl—CHRM4—Nicardipine—hypertension	0.1	0.274	CbGbCtD
Trihexyphenidyl—CHRM5—Nicardipine—hypertension	0.0982	0.268	CbGbCtD
Trihexyphenidyl—CHRM3—Nicardipine—hypertension	0.0627	0.171	CbGbCtD
Trihexyphenidyl—CHRM1—Nicardipine—hypertension	0.0546	0.149	CbGbCtD
Trihexyphenidyl—CHRM2—Nicardipine—hypertension	0.0503	0.137	CbGbCtD
Trihexyphenidyl—Tachycardia—Perindopril—hypertension	0.000166	0.000699	CcSEcCtD
Trihexyphenidyl—Dizziness—Guanabenz—hypertension	0.000165	0.000698	CcSEcCtD
Trihexyphenidyl—Dizziness—Metoprolol—hypertension	0.000165	0.000698	CcSEcCtD
Trihexyphenidyl—Tachycardia—Irbesartan—hypertension	0.000165	0.000696	CcSEcCtD
Trihexyphenidyl—Asthenia—Propranolol—hypertension	0.000165	0.000696	CcSEcCtD
Trihexyphenidyl—Confusional state—Betaxolol—hypertension	0.000165	0.000695	CcSEcCtD
Trihexyphenidyl—Tension—Ramipril—hypertension	0.000164	0.000692	CcSEcCtD
Trihexyphenidyl—Tachycardia—Hydrochlorothiazide—hypertension	0.000164	0.000691	CcSEcCtD
Trihexyphenidyl—Nausea—Eprosartan—hypertension	0.000163	0.000687	CcSEcCtD
Trihexyphenidyl—Somnolence—Trandolapril—hypertension	0.000163	0.000686	CcSEcCtD
Trihexyphenidyl—Nervousness—Ramipril—hypertension	0.000162	0.000685	CcSEcCtD
Trihexyphenidyl—Somnolence—Enalapril—hypertension	0.000162	0.000683	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Olmesartan—hypertension	0.000161	0.000681	CcSEcCtD
Trihexyphenidyl—Confusional state—Losartan—hypertension	0.00016	0.000677	CcSEcCtD
Trihexyphenidyl—Tension—Timolol—hypertension	0.00016	0.000677	CcSEcCtD
Trihexyphenidyl—Constipation—Clonidine—hypertension	0.00016	0.000677	CcSEcCtD
Trihexyphenidyl—Somnolence—Telmisartan—hypertension	0.00016	0.000674	CcSEcCtD
Trihexyphenidyl—Asthenia—Diltiazem—hypertension	0.000159	0.000673	CcSEcCtD
Trihexyphenidyl—Asthenia—Indapamide—hypertension	0.000159	0.000673	CcSEcCtD
Trihexyphenidyl—Tachycardia—Betaxolol—hypertension	0.000159	0.000673	CcSEcCtD
Trihexyphenidyl—Vomiting—Metoprolol—hypertension	0.000159	0.000671	CcSEcCtD
Trihexyphenidyl—Vomiting—Guanabenz—hypertension	0.000159	0.000671	CcSEcCtD
Trihexyphenidyl—Nervousness—Timolol—hypertension	0.000159	0.00067	CcSEcCtD
Trihexyphenidyl—Nausea—Amlodipine—hypertension	0.000158	0.000667	CcSEcCtD
Trihexyphenidyl—Nausea—Nisoldipine—hypertension	0.000158	0.000667	CcSEcCtD
Trihexyphenidyl—Asthenia—Carvedilol—hypertension	0.000158	0.000667	CcSEcCtD
Trihexyphenidyl—Rash—Guanabenz—hypertension	0.000158	0.000666	CcSEcCtD
Trihexyphenidyl—Rash—Metoprolol—hypertension	0.000158	0.000666	CcSEcCtD
Trihexyphenidyl—Dermatitis—Metoprolol—hypertension	0.000158	0.000665	CcSEcCtD
Trihexyphenidyl—Dermatitis—Guanabenz—hypertension	0.000158	0.000665	CcSEcCtD
Trihexyphenidyl—Headache—Guanabenz—hypertension	0.000157	0.000661	CcSEcCtD
Trihexyphenidyl—Headache—Metoprolol—hypertension	0.000157	0.000661	CcSEcCtD
Trihexyphenidyl—Constipation—Trandolapril—hypertension	0.000156	0.00066	CcSEcCtD
Trihexyphenidyl—Asthenia—Doxazosin—hypertension	0.000156	0.000659	CcSEcCtD
Trihexyphenidyl—Constipation—Enalapril—hypertension	0.000156	0.000657	CcSEcCtD
Trihexyphenidyl—Somnolence—Captopril—hypertension	0.000155	0.000656	CcSEcCtD
Trihexyphenidyl—Tachycardia—Losartan—hypertension	0.000155	0.000655	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Clonidine—hypertension	0.000154	0.000652	CcSEcCtD
Trihexyphenidyl—Asthenia—Fosinopril—hypertension	0.000154	0.000651	CcSEcCtD
Trihexyphenidyl—Vision blurred—Timolol—hypertension	0.000154	0.00065	CcSEcCtD
Trihexyphenidyl—Constipation—Telmisartan—hypertension	0.000154	0.000648	CcSEcCtD
Trihexyphenidyl—Agitation—Ramipril—hypertension	0.000154	0.000648	CcSEcCtD
Trihexyphenidyl—Asthenia—Eplerenone—hypertension	0.000153	0.000647	CcSEcCtD
Trihexyphenidyl—Asthenia—Nifedipine—hypertension	0.000152	0.000643	CcSEcCtD
Trihexyphenidyl—Dizziness—Propranolol—hypertension	0.000152	0.000641	CcSEcCtD
Trihexyphenidyl—Asthenia—Verapamil—hypertension	0.000152	0.00064	CcSEcCtD
Trihexyphenidyl—Somnolence—Perindopril—hypertension	0.000151	0.000636	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Trandolapril—hypertension	0.000151	0.000636	CcSEcCtD
Trihexyphenidyl—Somnolence—Irbesartan—hypertension	0.00015	0.000634	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Enalapril—hypertension	0.00015	0.000634	CcSEcCtD
Trihexyphenidyl—Constipation—Captopril—hypertension	0.000149	0.000631	CcSEcCtD
Trihexyphenidyl—Somnolence—Hydrochlorothiazide—hypertension	0.000149	0.000629	CcSEcCtD
Trihexyphenidyl—Tension—Lisinopril—hypertension	0.000149	0.000628	CcSEcCtD
Trihexyphenidyl—Nausea—Metoprolol—hypertension	0.000149	0.000627	CcSEcCtD
Trihexyphenidyl—Nausea—Guanabenz—hypertension	0.000149	0.000627	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Telmisartan—hypertension	0.000148	0.000625	CcSEcCtD
Trihexyphenidyl—Nervousness—Lisinopril—hypertension	0.000147	0.000621	CcSEcCtD
Trihexyphenidyl—Dizziness—Indapamide—hypertension	0.000147	0.000621	CcSEcCtD
Trihexyphenidyl—Dizziness—Diltiazem—hypertension	0.000147	0.000621	CcSEcCtD
Trihexyphenidyl—Somnolence—Furosemide—hypertension	0.000147	0.000619	CcSEcCtD
Trihexyphenidyl—Vomiting—Propranolol—hypertension	0.000146	0.000616	CcSEcCtD
Trihexyphenidyl—Dizziness—Carvedilol—hypertension	0.000146	0.000615	CcSEcCtD
Trihexyphenidyl—Constipation—Perindopril—hypertension	0.000145	0.000612	CcSEcCtD
Trihexyphenidyl—Rash—Propranolol—hypertension	0.000145	0.000611	CcSEcCtD
Trihexyphenidyl—Dermatitis—Propranolol—hypertension	0.000145	0.000611	CcSEcCtD
Trihexyphenidyl—Constipation—Irbesartan—hypertension	0.000145	0.00061	CcSEcCtD
Trihexyphenidyl—Dizziness—Doxazosin—hypertension	0.000144	0.000608	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Captopril—hypertension	0.000144	0.000608	CcSEcCtD
Trihexyphenidyl—Constipation—Hydrochlorothiazide—hypertension	0.000143	0.000605	CcSEcCtD
Trihexyphenidyl—Vision blurred—Lisinopril—hypertension	0.000143	0.000603	CcSEcCtD
Trihexyphenidyl—Dizziness—Fosinopril—hypertension	0.000142	0.0006	CcSEcCtD
Trihexyphenidyl—Somnolence—Losartan—hypertension	0.000141	0.000597	CcSEcCtD
Trihexyphenidyl—Dizziness—Eplerenone—hypertension	0.000141	0.000597	CcSEcCtD
Trihexyphenidyl—Vomiting—Indapamide—hypertension	0.000141	0.000597	CcSEcCtD
Trihexyphenidyl—Vomiting—Diltiazem—hypertension	0.000141	0.000597	CcSEcCtD
Trihexyphenidyl—Asthenia—Valsartan—hypertension	0.000141	0.000596	CcSEcCtD
Trihexyphenidyl—Constipation—Furosemide—hypertension	0.000141	0.000595	CcSEcCtD
Trihexyphenidyl—Asthenia—Olmesartan—hypertension	0.00014	0.000593	CcSEcCtD
Trihexyphenidyl—Dizziness—Nifedipine—hypertension	0.00014	0.000592	CcSEcCtD
Trihexyphenidyl—Rash—Indapamide—hypertension	0.00014	0.000592	CcSEcCtD
Trihexyphenidyl—Rash—Diltiazem—hypertension	0.00014	0.000592	CcSEcCtD
Trihexyphenidyl—Dermatitis—Diltiazem—hypertension	0.00014	0.000591	CcSEcCtD
Trihexyphenidyl—Dermatitis—Indapamide—hypertension	0.00014	0.000591	CcSEcCtD
Trihexyphenidyl—Vomiting—Carvedilol—hypertension	0.00014	0.000591	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Perindopril—hypertension	0.00014	0.00059	CcSEcCtD
Trihexyphenidyl—Dizziness—Verapamil—hypertension	0.00014	0.00059	CcSEcCtD
Trihexyphenidyl—Constipation—Betaxolol—hypertension	0.00014	0.000589	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Irbesartan—hypertension	0.000139	0.000588	CcSEcCtD
Trihexyphenidyl—Headache—Diltiazem—hypertension	0.000139	0.000588	CcSEcCtD
Trihexyphenidyl—Headache—Indapamide—hypertension	0.000139	0.000588	CcSEcCtD
Trihexyphenidyl—Rash—Carvedilol—hypertension	0.000139	0.000586	CcSEcCtD
Trihexyphenidyl—Dermatitis—Carvedilol—hypertension	0.000139	0.000585	CcSEcCtD
Trihexyphenidyl—Vomiting—Doxazosin—hypertension	0.000138	0.000584	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Hydrochlorothiazide—hypertension	0.000138	0.000583	CcSEcCtD
Trihexyphenidyl—Headache—Carvedilol—hypertension	0.000138	0.000582	CcSEcCtD
Trihexyphenidyl—Confusional state—Ramipril—hypertension	0.000138	0.000581	CcSEcCtD
Trihexyphenidyl—Rash—Doxazosin—hypertension	0.000137	0.000579	CcSEcCtD
Trihexyphenidyl—Dermatitis—Doxazosin—hypertension	0.000137	0.000579	CcSEcCtD
Trihexyphenidyl—Vomiting—Fosinopril—hypertension	0.000137	0.000577	CcSEcCtD
Trihexyphenidyl—Nausea—Propranolol—hypertension	0.000136	0.000576	CcSEcCtD
Trihexyphenidyl—Headache—Doxazosin—hypertension	0.000136	0.000576	CcSEcCtD
Trihexyphenidyl—Constipation—Losartan—hypertension	0.000136	0.000574	CcSEcCtD
Trihexyphenidyl—Vomiting—Eplerenone—hypertension	0.000136	0.000574	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Furosemide—hypertension	0.000136	0.000574	CcSEcCtD
Trihexyphenidyl—Rash—Fosinopril—hypertension	0.000136	0.000572	CcSEcCtD
Trihexyphenidyl—Dermatitis—Fosinopril—hypertension	0.000135	0.000572	CcSEcCtD
Trihexyphenidyl—Vomiting—Nifedipine—hypertension	0.000135	0.00057	CcSEcCtD
Trihexyphenidyl—Rash—Eplerenone—hypertension	0.000135	0.000569	CcSEcCtD
Trihexyphenidyl—Headache—Fosinopril—hypertension	0.000135	0.000569	CcSEcCtD
Trihexyphenidyl—Dermatitis—Eplerenone—hypertension	0.000135	0.000568	CcSEcCtD
Trihexyphenidyl—Asthenia—Clonidine—hypertension	0.000135	0.000568	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Betaxolol—hypertension	0.000135	0.000568	CcSEcCtD
Trihexyphenidyl—Confusional state—Timolol—hypertension	0.000134	0.000568	CcSEcCtD
Trihexyphenidyl—Vomiting—Verapamil—hypertension	0.000134	0.000567	CcSEcCtD
Trihexyphenidyl—Headache—Eplerenone—hypertension	0.000134	0.000565	CcSEcCtD
Trihexyphenidyl—Rash—Nifedipine—hypertension	0.000134	0.000565	CcSEcCtD
Trihexyphenidyl—Dermatitis—Nifedipine—hypertension	0.000134	0.000564	CcSEcCtD
Trihexyphenidyl—Rash—Verapamil—hypertension	0.000133	0.000562	CcSEcCtD
Trihexyphenidyl—Tachycardia—Ramipril—hypertension	0.000133	0.000562	CcSEcCtD
Trihexyphenidyl—Dermatitis—Verapamil—hypertension	0.000133	0.000562	CcSEcCtD
Trihexyphenidyl—Headache—Nifedipine—hypertension	0.000133	0.000561	CcSEcCtD
Trihexyphenidyl—Headache—Verapamil—hypertension	0.000132	0.000559	CcSEcCtD
Trihexyphenidyl—Nausea—Diltiazem—hypertension	0.000132	0.000557	CcSEcCtD
Trihexyphenidyl—Nausea—Indapamide—hypertension	0.000132	0.000557	CcSEcCtD
Trihexyphenidyl—Asthenia—Trandolapril—hypertension	0.000131	0.000554	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Losartan—hypertension	0.000131	0.000553	CcSEcCtD
Trihexyphenidyl—Nausea—Carvedilol—hypertension	0.000131	0.000552	CcSEcCtD
Trihexyphenidyl—Asthenia—Enalapril—hypertension	0.000131	0.000552	CcSEcCtD
Trihexyphenidyl—Dizziness—Valsartan—hypertension	0.00013	0.000549	CcSEcCtD
Trihexyphenidyl—Dizziness—Olmesartan—hypertension	0.000129	0.000546	CcSEcCtD
Trihexyphenidyl—Nausea—Doxazosin—hypertension	0.000129	0.000546	CcSEcCtD
Trihexyphenidyl—Asthenia—Telmisartan—hypertension	0.000129	0.000544	CcSEcCtD
Trihexyphenidyl—Nausea—Fosinopril—hypertension	0.000128	0.000539	CcSEcCtD
Trihexyphenidyl—Nausea—Eplerenone—hypertension	0.000127	0.000536	CcSEcCtD
Trihexyphenidyl—Nausea—Nifedipine—hypertension	0.000126	0.000532	CcSEcCtD
Trihexyphenidyl—Nausea—Verapamil—hypertension	0.000125	0.00053	CcSEcCtD
Trihexyphenidyl—Asthenia—Captopril—hypertension	0.000125	0.000529	CcSEcCtD
Trihexyphenidyl—Vomiting—Valsartan—hypertension	0.000125	0.000528	CcSEcCtD
Trihexyphenidyl—Confusional state—Lisinopril—hypertension	0.000125	0.000527	CcSEcCtD
Trihexyphenidyl—Vomiting—Olmesartan—hypertension	0.000124	0.000525	CcSEcCtD
Trihexyphenidyl—Rash—Valsartan—hypertension	0.000124	0.000524	CcSEcCtD
Trihexyphenidyl—Dizziness—Clonidine—hypertension	0.000124	0.000523	CcSEcCtD
Trihexyphenidyl—Dermatitis—Valsartan—hypertension	0.000124	0.000523	CcSEcCtD
Trihexyphenidyl—Rash—Olmesartan—hypertension	0.000123	0.000521	CcSEcCtD
Trihexyphenidyl—Dermatitis—Olmesartan—hypertension	0.000123	0.000521	CcSEcCtD
Trihexyphenidyl—Headache—Valsartan—hypertension	0.000123	0.00052	CcSEcCtD
Trihexyphenidyl—Headache—Olmesartan—hypertension	0.000123	0.000518	CcSEcCtD
Trihexyphenidyl—Asthenia—Perindopril—hypertension	0.000122	0.000514	CcSEcCtD
Trihexyphenidyl—Asthenia—Irbesartan—hypertension	0.000121	0.000512	CcSEcCtD
Trihexyphenidyl—Somnolence—Ramipril—hypertension	0.000121	0.000512	CcSEcCtD
Trihexyphenidyl—Dizziness—Trandolapril—hypertension	0.000121	0.00051	CcSEcCtD
Trihexyphenidyl—Tachycardia—Lisinopril—hypertension	0.000121	0.00051	CcSEcCtD
Trihexyphenidyl—Dizziness—Enalapril—hypertension	0.00012	0.000508	CcSEcCtD
Trihexyphenidyl—Asthenia—Hydrochlorothiazide—hypertension	0.00012	0.000508	CcSEcCtD
Trihexyphenidyl—Vomiting—Clonidine—hypertension	0.000119	0.000503	CcSEcCtD
Trihexyphenidyl—Dizziness—Telmisartan—hypertension	0.000119	0.000501	CcSEcCtD
Trihexyphenidyl—Somnolence—Timolol—hypertension	0.000119	0.0005	CcSEcCtD
Trihexyphenidyl—Asthenia—Furosemide—hypertension	0.000118	0.000499	CcSEcCtD
Trihexyphenidyl—Rash—Clonidine—hypertension	0.000118	0.000499	CcSEcCtD
Trihexyphenidyl—Dermatitis—Clonidine—hypertension	0.000118	0.000499	CcSEcCtD
Trihexyphenidyl—Headache—Clonidine—hypertension	0.000117	0.000496	CcSEcCtD
Trihexyphenidyl—Asthenia—Betaxolol—hypertension	0.000117	0.000494	CcSEcCtD
Trihexyphenidyl—Nausea—Valsartan—hypertension	0.000117	0.000493	CcSEcCtD
Trihexyphenidyl—Constipation—Ramipril—hypertension	0.000117	0.000492	CcSEcCtD
Trihexyphenidyl—Nausea—Olmesartan—hypertension	0.000116	0.000491	CcSEcCtD
Trihexyphenidyl—Vomiting—Trandolapril—hypertension	0.000116	0.000491	CcSEcCtD
Trihexyphenidyl—Vomiting—Enalapril—hypertension	0.000116	0.000489	CcSEcCtD
Trihexyphenidyl—Dizziness—Captopril—hypertension	0.000116	0.000488	CcSEcCtD
Trihexyphenidyl—Rash—Trandolapril—hypertension	0.000115	0.000487	CcSEcCtD
Trihexyphenidyl—Dermatitis—Trandolapril—hypertension	0.000115	0.000486	CcSEcCtD
Trihexyphenidyl—Rash—Enalapril—hypertension	0.000115	0.000485	CcSEcCtD
Trihexyphenidyl—Dermatitis—Enalapril—hypertension	0.000115	0.000484	CcSEcCtD
Trihexyphenidyl—Headache—Trandolapril—hypertension	0.000115	0.000484	CcSEcCtD
Trihexyphenidyl—Vomiting—Telmisartan—hypertension	0.000114	0.000482	CcSEcCtD
Trihexyphenidyl—Asthenia—Losartan—hypertension	0.000114	0.000482	CcSEcCtD
Trihexyphenidyl—Headache—Enalapril—hypertension	0.000114	0.000482	CcSEcCtD
Trihexyphenidyl—Rash—Telmisartan—hypertension	0.000113	0.000478	CcSEcCtD
Trihexyphenidyl—Dermatitis—Telmisartan—hypertension	0.000113	0.000478	CcSEcCtD
Trihexyphenidyl—Headache—Telmisartan—hypertension	0.000113	0.000475	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Ramipril—hypertension	0.000112	0.000474	CcSEcCtD
Trihexyphenidyl—Dizziness—Perindopril—hypertension	0.000112	0.000473	CcSEcCtD
Trihexyphenidyl—Dizziness—Irbesartan—hypertension	0.000112	0.000472	CcSEcCtD
Trihexyphenidyl—Nausea—Clonidine—hypertension	0.000111	0.00047	CcSEcCtD
Trihexyphenidyl—Vomiting—Captopril—hypertension	0.000111	0.000469	CcSEcCtD
Trihexyphenidyl—Dizziness—Hydrochlorothiazide—hypertension	0.000111	0.000468	CcSEcCtD
Trihexyphenidyl—Rash—Captopril—hypertension	0.00011	0.000465	CcSEcCtD
Trihexyphenidyl—Dermatitis—Captopril—hypertension	0.00011	0.000465	CcSEcCtD
Trihexyphenidyl—Somnolence—Lisinopril—hypertension	0.00011	0.000464	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Timolol—hypertension	0.00011	0.000464	CcSEcCtD
Trihexyphenidyl—Headache—Captopril—hypertension	0.000109	0.000462	CcSEcCtD
Trihexyphenidyl—Dizziness—Furosemide—hypertension	0.000109	0.00046	CcSEcCtD
Trihexyphenidyl—Nausea—Trandolapril—hypertension	0.000109	0.000459	CcSEcCtD
Trihexyphenidyl—Nausea—Enalapril—hypertension	0.000108	0.000457	CcSEcCtD
Trihexyphenidyl—Dizziness—Betaxolol—hypertension	0.000108	0.000456	CcSEcCtD
Trihexyphenidyl—Vomiting—Perindopril—hypertension	0.000108	0.000455	CcSEcCtD
Trihexyphenidyl—Vomiting—Irbesartan—hypertension	0.000107	0.000454	CcSEcCtD
Trihexyphenidyl—Rash—Perindopril—hypertension	0.000107	0.000451	CcSEcCtD
Trihexyphenidyl—Dermatitis—Perindopril—hypertension	0.000107	0.000451	CcSEcCtD
Trihexyphenidyl—Nausea—Telmisartan—hypertension	0.000107	0.00045	CcSEcCtD
Trihexyphenidyl—Vomiting—Hydrochlorothiazide—hypertension	0.000107	0.00045	CcSEcCtD
Trihexyphenidyl—Rash—Irbesartan—hypertension	0.000107	0.00045	CcSEcCtD
Trihexyphenidyl—Dermatitis—Irbesartan—hypertension	0.000106	0.000449	CcSEcCtD
Trihexyphenidyl—Headache—Perindopril—hypertension	0.000106	0.000449	CcSEcCtD
Trihexyphenidyl—Headache—Irbesartan—hypertension	0.000106	0.000447	CcSEcCtD
Trihexyphenidyl—Constipation—Lisinopril—hypertension	0.000106	0.000447	CcSEcCtD
Trihexyphenidyl—Rash—Hydrochlorothiazide—hypertension	0.000106	0.000446	CcSEcCtD
Trihexyphenidyl—Dermatitis—Hydrochlorothiazide—hypertension	0.000106	0.000446	CcSEcCtD
Trihexyphenidyl—Dizziness—Losartan—hypertension	0.000105	0.000444	CcSEcCtD
Trihexyphenidyl—Headache—Hydrochlorothiazide—hypertension	0.000105	0.000443	CcSEcCtD
Trihexyphenidyl—Vomiting—Furosemide—hypertension	0.000105	0.000443	CcSEcCtD
Trihexyphenidyl—Rash—Furosemide—hypertension	0.000104	0.000439	CcSEcCtD
Trihexyphenidyl—Dermatitis—Furosemide—hypertension	0.000104	0.000438	CcSEcCtD
Trihexyphenidyl—Vomiting—Betaxolol—hypertension	0.000104	0.000438	CcSEcCtD
Trihexyphenidyl—Nausea—Captopril—hypertension	0.000104	0.000438	CcSEcCtD
Trihexyphenidyl—Headache—Furosemide—hypertension	0.000103	0.000436	CcSEcCtD
Trihexyphenidyl—Rash—Betaxolol—hypertension	0.000103	0.000434	CcSEcCtD
Trihexyphenidyl—Dermatitis—Betaxolol—hypertension	0.000103	0.000434	CcSEcCtD
Trihexyphenidyl—Headache—Betaxolol—hypertension	0.000102	0.000432	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Lisinopril—hypertension	0.000102	0.00043	CcSEcCtD
Trihexyphenidyl—Vomiting—Losartan—hypertension	0.000101	0.000427	CcSEcCtD
Trihexyphenidyl—Nausea—Perindopril—hypertension	0.000101	0.000425	CcSEcCtD
Trihexyphenidyl—Nausea—Irbesartan—hypertension	0.0001	0.000424	CcSEcCtD
Trihexyphenidyl—Rash—Losartan—hypertension	0.0001	0.000423	CcSEcCtD
Trihexyphenidyl—Dermatitis—Losartan—hypertension	0.0001	0.000423	CcSEcCtD
Trihexyphenidyl—Headache—Losartan—hypertension	9.97e-05	0.000421	CcSEcCtD
Trihexyphenidyl—Nausea—Hydrochlorothiazide—hypertension	9.96e-05	0.00042	CcSEcCtD
Trihexyphenidyl—Nausea—Furosemide—hypertension	9.79e-05	0.000413	CcSEcCtD
Trihexyphenidyl—Asthenia—Ramipril—hypertension	9.79e-05	0.000413	CcSEcCtD
Trihexyphenidyl—Nausea—Betaxolol—hypertension	9.7e-05	0.000409	CcSEcCtD
Trihexyphenidyl—Asthenia—Timolol—hypertension	9.57e-05	0.000404	CcSEcCtD
Trihexyphenidyl—Nausea—Losartan—hypertension	9.45e-05	0.000399	CcSEcCtD
Trihexyphenidyl—Dizziness—Ramipril—hypertension	9.02e-05	0.000381	CcSEcCtD
Trihexyphenidyl—Asthenia—Lisinopril—hypertension	8.88e-05	0.000375	CcSEcCtD
Trihexyphenidyl—Dizziness—Timolol—hypertension	8.82e-05	0.000372	CcSEcCtD
Trihexyphenidyl—Vomiting—Ramipril—hypertension	8.67e-05	0.000366	CcSEcCtD
Trihexyphenidyl—Rash—Ramipril—hypertension	8.6e-05	0.000363	CcSEcCtD
Trihexyphenidyl—Dermatitis—Ramipril—hypertension	8.59e-05	0.000363	CcSEcCtD
Trihexyphenidyl—Headache—Ramipril—hypertension	8.54e-05	0.000361	CcSEcCtD
Trihexyphenidyl—Vomiting—Timolol—hypertension	8.48e-05	0.000358	CcSEcCtD
Trihexyphenidyl—Rash—Timolol—hypertension	8.41e-05	0.000355	CcSEcCtD
Trihexyphenidyl—Dermatitis—Timolol—hypertension	8.4e-05	0.000355	CcSEcCtD
Trihexyphenidyl—Headache—Timolol—hypertension	8.35e-05	0.000353	CcSEcCtD
Trihexyphenidyl—Dizziness—Lisinopril—hypertension	8.18e-05	0.000345	CcSEcCtD
Trihexyphenidyl—Nausea—Ramipril—hypertension	8.1e-05	0.000342	CcSEcCtD
Trihexyphenidyl—Nausea—Timolol—hypertension	7.92e-05	0.000334	CcSEcCtD
Trihexyphenidyl—Vomiting—Lisinopril—hypertension	7.87e-05	0.000332	CcSEcCtD
Trihexyphenidyl—Rash—Lisinopril—hypertension	7.8e-05	0.000329	CcSEcCtD
Trihexyphenidyl—Dermatitis—Lisinopril—hypertension	7.79e-05	0.000329	CcSEcCtD
Trihexyphenidyl—Headache—Lisinopril—hypertension	7.75e-05	0.000327	CcSEcCtD
Trihexyphenidyl—Nausea—Lisinopril—hypertension	7.35e-05	0.00031	CcSEcCtD
Trihexyphenidyl—CHRM3—Signaling Pathways—CCL5—hypertension	6.35e-06	3.63e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—EDN1—hypertension	6.33e-06	3.62e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—INS—hypertension	6.33e-06	3.62e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CCL5—hypertension	6.28e-06	3.59e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—CALM1—hypertension	6.24e-06	3.57e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CCL2—hypertension	6.23e-06	3.56e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—LPL—hypertension	6.22e-06	3.56e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—APOE—hypertension	6.22e-06	3.56e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—LPL—hypertension	6.2e-06	3.55e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—H2AFX—hypertension	6.18e-06	3.53e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—RPS6KB1—hypertension	6.17e-06	3.53e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—PDGFRB—hypertension	6.17e-06	3.53e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—CAV1—hypertension	6.16e-06	3.52e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—H2AFX—hypertension	6.16e-06	3.52e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—RPS6KB1—hypertension	6.15e-06	3.52e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—PDGFRB—hypertension	6.15e-06	3.52e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—APOA1—hypertension	6.15e-06	3.52e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—LPL—hypertension	6.14e-06	3.51e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—IGF1—hypertension	6.12e-06	3.5e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—AKT2—hypertension	6.12e-06	3.5e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—H2AFX—hypertension	6.1e-06	3.49e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—ADCY5—hypertension	6.09e-06	3.48e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—EGFR—hypertension	6.09e-06	3.48e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—PDGFRB—hypertension	6.09e-06	3.48e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—RPS6KB1—hypertension	6.09e-06	3.48e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—ADCY5—hypertension	6.07e-06	3.47e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—SERPINE1—hypertension	6.07e-06	3.47e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—PRKCG—hypertension	6.05e-06	3.46e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—PRKCG—hypertension	6.03e-06	3.45e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—ADCY5—hypertension	6.02e-06	3.44e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—ITGB3—hypertension	6.01e-06	3.44e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—PRKCA—hypertension	6.01e-06	3.44e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—ITGB3—hypertension	5.99e-06	3.43e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—PRKCA—hypertension	5.99e-06	3.43e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—PRKCG—hypertension	5.97e-06	3.42e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—YWHAZ—hypertension	5.96e-06	3.41e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—YWHAZ—hypertension	5.94e-06	3.4e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—ITGB3—hypertension	5.93e-06	3.39e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—PRKCA—hypertension	5.93e-06	3.39e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—NGF—hypertension	5.9e-06	3.37e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—SPP1—hypertension	5.9e-06	3.37e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—YWHAZ—hypertension	5.89e-06	3.37e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—FGF2—hypertension	5.88e-06	3.36e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—NGF—hypertension	5.88e-06	3.36e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—SPP1—hypertension	5.88e-06	3.36e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—CXCL8—hypertension	5.87e-06	3.36e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—RHOA—hypertension	5.86e-06	3.35e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—CXCL8—hypertension	5.85e-06	3.35e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—SPP1—hypertension	5.82e-06	3.33e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—NGF—hypertension	5.82e-06	3.33e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—SERPINE1—hypertension	5.82e-06	3.32e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—PIK3R1—hypertension	5.8e-06	3.31e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—NOS3—hypertension	5.8e-06	3.31e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—CXCL8—hypertension	5.79e-06	3.31e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—PRKCD—hypertension	5.74e-06	3.28e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CCR5—hypertension	5.74e-06	3.28e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CCR5—hypertension	5.72e-06	3.27e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—PRKCD—hypertension	5.72e-06	3.27e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—PRKCD—hypertension	5.66e-06	3.24e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CCR5—hypertension	5.66e-06	3.24e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—FGF2—hypertension	5.63e-06	3.22e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—HTR2A—hypertension	5.61e-06	3.21e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—RHOA—hypertension	5.61e-06	3.21e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—C3—hypertension	5.6e-06	3.2e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—HTR2A—hypertension	5.59e-06	3.2e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—C3—hypertension	5.59e-06	3.19e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—PIK3R1—hypertension	5.55e-06	3.17e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—NOS3—hypertension	5.55e-06	3.17e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—HTR2A—hypertension	5.54e-06	3.17e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—C3—hypertension	5.53e-06	3.16e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—RELA—hypertension	5.46e-06	3.12e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—PDGFB—hypertension	5.46e-06	3.12e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—PDGFB—hypertension	5.44e-06	3.11e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—FGFR1—hypertension	5.43e-06	3.1e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—PPARG—hypertension	5.42e-06	3.1e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—FGFR1—hypertension	5.41e-06	3.09e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—PDGFB—hypertension	5.38e-06	3.08e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—FGFR1—hypertension	5.36e-06	3.06e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—MTOR—hypertension	5.35e-06	3.06e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—HIF1A—hypertension	5.35e-06	3.06e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—POMC—hypertension	5.34e-06	3.06e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—HIF1A—hypertension	5.33e-06	3.05e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—AGT—hypertension	5.33e-06	3.04e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—INS—hypertension	5.31e-06	3.04e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—AGT—hypertension	5.31e-06	3.03e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—HIF1A—hypertension	5.28e-06	3.02e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—AGT—hypertension	5.26e-06	3.01e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CALM1—hypertension	5.24e-06	2.99e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—RELA—hypertension	5.23e-06	2.99e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CALM1—hypertension	5.22e-06	2.98e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—LEP—hypertension	5.22e-06	2.98e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—APOE—hypertension	5.22e-06	2.98e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—LEP—hypertension	5.2e-06	2.97e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—APOE—hypertension	5.2e-06	2.97e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CAV1—hypertension	5.17e-06	2.96e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CALM1—hypertension	5.17e-06	2.96e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—APOA1—hypertension	5.16e-06	2.95e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CAV1—hypertension	5.15e-06	2.95e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—LEP—hypertension	5.15e-06	2.94e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—APOE—hypertension	5.15e-06	2.94e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CXCL8—hypertension	5.14e-06	2.94e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—APOA1—hypertension	5.14e-06	2.94e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—MTOR—hypertension	5.12e-06	2.93e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—KDR—hypertension	5.11e-06	2.92e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CAV1—hypertension	5.1e-06	2.92e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—KDR—hypertension	5.1e-06	2.91e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—APOA1—hypertension	5.09e-06	2.91e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—KDR—hypertension	5.05e-06	2.88e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—AKT1—hypertension	4.97e-06	2.84e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CXCL8—hypertension	4.92e-06	2.82e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—F2—hypertension	4.92e-06	2.81e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—PRKCB—hypertension	4.92e-06	2.81e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—FN1—hypertension	4.92e-06	2.81e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—PRKCB—hypertension	4.9e-06	2.8e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—FN1—hypertension	4.9e-06	2.8e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—F2—hypertension	4.9e-06	2.8e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—IL6—hypertension	4.89e-06	2.8e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—ALB—hypertension	4.87e-06	2.79e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—PRKCB—hypertension	4.86e-06	2.78e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—FN1—hypertension	4.86e-06	2.78e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—F2—hypertension	4.86e-06	2.78e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—NOTCH1—hypertension	4.82e-06	2.75e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—NOTCH1—hypertension	4.8e-06	2.74e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—AKT1—hypertension	4.76e-06	2.72e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—NOTCH1—hypertension	4.75e-06	2.72e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—IL6—hypertension	4.68e-06	2.68e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—PIK3R1—hypertension	4.66e-06	2.66e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—NOS3—hypertension	4.66e-06	2.66e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—MMP9—hypertension	4.65e-06	2.66e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CDKN1A—hypertension	4.63e-06	2.65e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—PTEN—hypertension	4.62e-06	2.64e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—MAPK8—hypertension	4.52e-06	2.59e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—AKT1—hypertension	4.51e-06	2.58e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—POMC—hypertension	4.48e-06	2.56e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—POMC—hypertension	4.47e-06	2.55e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—INS—hypertension	4.46e-06	2.55e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—MMP9—hypertension	4.45e-06	2.55e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—INS—hypertension	4.44e-06	2.54e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CDKN1A—hypertension	4.44e-06	2.54e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—PTEN—hypertension	4.43e-06	2.53e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—POMC—hypertension	4.42e-06	2.53e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—EP300—hypertension	4.41e-06	2.52e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—INS—hypertension	4.4e-06	2.52e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CCL2—hypertension	4.39e-06	2.51e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CCL2—hypertension	4.37e-06	2.5e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—MAPK8—hypertension	4.33e-06	2.48e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CCL2—hypertension	4.33e-06	2.48e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—AKT1—hypertension	4.32e-06	2.47e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—IGF1—hypertension	4.31e-06	2.47e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—AKT2—hypertension	4.31e-06	2.46e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—IGF1—hypertension	4.3e-06	2.46e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—AKT2—hypertension	4.29e-06	2.46e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—EGFR—hypertension	4.29e-06	2.45e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—SRC—hypertension	4.29e-06	2.45e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—EGFR—hypertension	4.28e-06	2.45e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—PTGS2—hypertension	4.26e-06	2.44e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—IGF1—hypertension	4.26e-06	2.43e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—AKT2—hypertension	4.25e-06	2.43e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—EGFR—hypertension	4.24e-06	2.42e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—EP300—hypertension	4.22e-06	2.41e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—VEGFA—hypertension	4.18e-06	2.39e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—SRC—hypertension	4.11e-06	2.35e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—SERPINE1—hypertension	4.09e-06	2.34e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—SERPINE1—hypertension	4.08e-06	2.33e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—SERPINE1—hypertension	4.04e-06	2.31e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—VEGFA—hypertension	4e-06	2.29e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—FGF2—hypertension	3.96e-06	2.27e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—FGF2—hypertension	3.95e-06	2.26e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—RHOA—hypertension	3.95e-06	2.26e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—RHOA—hypertension	3.94e-06	2.25e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—FGF2—hypertension	3.91e-06	2.24e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—NOS3—hypertension	3.91e-06	2.23e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—PIK3R1—hypertension	3.91e-06	2.23e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—RHOA—hypertension	3.9e-06	2.23e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—PIK3R1—hypertension	3.9e-06	2.23e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—NOS3—hypertension	3.9e-06	2.23e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—PIK3R1—hypertension	3.86e-06	2.21e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—NOS3—hypertension	3.86e-06	2.21e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—MYC—hypertension	3.84e-06	2.2e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—TGFB1—hypertension	3.83e-06	2.19e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—EGFR—hypertension	3.76e-06	2.15e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—PTEN—hypertension	3.72e-06	2.13e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—MYC—hypertension	3.68e-06	2.1e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—RELA—hypertension	3.68e-06	2.1e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—TGFB1—hypertension	3.67e-06	2.1e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—RELA—hypertension	3.67e-06	2.1e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—RELA—hypertension	3.63e-06	2.08e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—MTOR—hypertension	3.61e-06	2.06e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—EGFR—hypertension	3.6e-06	2.06e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—MTOR—hypertension	3.6e-06	2.06e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—MTOR—hypertension	3.56e-06	2.04e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—EP300—hypertension	3.54e-06	2.03e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CXCL8—hypertension	3.47e-06	1.98e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CXCL8—hypertension	3.46e-06	1.98e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CXCL8—hypertension	3.42e-06	1.96e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—AKT1—hypertension	3.35e-06	1.92e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—AKT1—hypertension	3.34e-06	1.91e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—AKT1—hypertension	3.31e-06	1.89e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—IL6—hypertension	3.3e-06	1.89e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—IL6—hypertension	3.29e-06	1.88e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—IL6—hypertension	3.25e-06	1.86e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—TP53—hypertension	3.16e-06	1.8e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—MMP9—hypertension	3.14e-06	1.79e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—MMP9—hypertension	3.13e-06	1.79e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CDKN1A—hypertension	3.12e-06	1.79e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—PTEN—hypertension	3.12e-06	1.78e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CDKN1A—hypertension	3.12e-06	1.78e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—PTEN—hypertension	3.11e-06	1.78e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—MMP9—hypertension	3.1e-06	1.77e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CDKN1A—hypertension	3.08e-06	1.76e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—PTEN—hypertension	3.08e-06	1.76e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—MAPK8—hypertension	3.05e-06	1.74e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—AKT1—hypertension	3.04e-06	1.74e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—MAPK8—hypertension	3.04e-06	1.74e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—AKT1—hypertension	3.03e-06	1.73e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—TP53—hypertension	3.02e-06	1.73e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—MAPK8—hypertension	3.01e-06	1.72e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—AKT1—hypertension	3e-06	1.72e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—EP300—hypertension	2.97e-06	1.7e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—EP300—hypertension	2.96e-06	1.69e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—EP300—hypertension	2.94e-06	1.68e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—SRC—hypertension	2.89e-06	1.65e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—IL6—hypertension	2.89e-06	1.65e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—SRC—hypertension	2.88e-06	1.65e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—SRC—hypertension	2.85e-06	1.63e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—VEGFA—hypertension	2.82e-06	1.61e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—VEGFA—hypertension	2.81e-06	1.6e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—VEGFA—hypertension	2.78e-06	1.59e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—IL6—hypertension	2.77e-06	1.58e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—AKT1—hypertension	2.66e-06	1.52e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—MYC—hypertension	2.59e-06	1.48e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—TGFB1—hypertension	2.58e-06	1.48e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—MYC—hypertension	2.58e-06	1.48e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—TGFB1—hypertension	2.58e-06	1.47e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—MYC—hypertension	2.56e-06	1.46e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—AKT1—hypertension	2.55e-06	1.46e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—TGFB1—hypertension	2.55e-06	1.46e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—EGFR—hypertension	2.53e-06	1.45e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—EGFR—hypertension	2.53e-06	1.44e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—EGFR—hypertension	2.5e-06	1.43e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—AKT1—hypertension	2.14e-06	1.22e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—TP53—hypertension	2.13e-06	1.22e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—TP53—hypertension	2.12e-06	1.21e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—TP53—hypertension	2.1e-06	1.2e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—IL6—hypertension	1.95e-06	1.11e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—IL6—hypertension	1.94e-06	1.11e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—IL6—hypertension	1.92e-06	1.1e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—AKT1—hypertension	1.8e-06	1.03e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—AKT1—hypertension	1.79e-06	1.02e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—AKT1—hypertension	1.77e-06	1.01e-05	CbGpPWpGaD
